Cytologics has taken the bold step to ensure an abundant provision of human immune cell products, including isolated PBMCs, Pan T cells, cytotoxic T cells, NK cells and B cells. Founded in 2018, Cytologics provides ethically sourced and high-quality human biological material for researchers developing new therapies and diagnostics. With coast-to-coast collection facilities, the company’s team of trained and certified experts oversees each step of the process, from cell sourcing to delivering the final product.